tirzepatide and menopause New research from a Mayo Clinic–led study suggests that postmenopausal women using hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight obesity. In Join Josie Review - Inside

How They Work: Dual-Receptor vs Single-Receptor Wegovy (semaglutide) mimics one gut hormone glucagon-like peptide-1 (GLP-1)

Fatty Acid Oxidation and Carnitine Palmitoyltransferase I: Emerging Therapeutic Targets in Cancer

And so one of the problems that has caused a lot of controversy, and I think the reason theres so much back and forth over this, is that it takes the right type of study to see seed oils making your tissues more vulnerable to damage, because you need enough time for the damage to play out and you need people who are more vulnerable to the damage

This covers your current weight, height, medical conditions, medications, and weight loss goals